Literature DB >> 17217618

In vivo imaging of molecularly targeted phage.

Kimberly A Kelly1, Peter Waterman, Ralph Weissleder.   

Abstract

Rapid identification of in vivo affinity ligands would have far-reaching applications for imaging specific molecular targets, in vivo systems imaging, and medical use. We have developed a high-throughput method for identifying and optimizing ligands to map and image biologic targets of interest in vivo. We directly labeled viable phage clones with far-red fluorochromes and comparatively imaged them in vivo by multichannel fluorescence ratio imaging. Using Secreted Protein Acidic and Rich in Cysteine (osteonectin) and vascular cell adhesion molecule-1 as model targets, we show that: 1) fluorescently labeled phage retains target specificity on labeling; 2) in vivo distribution can be quantitated (detection thresholds of approximately 300 phage/mm(3) tissue) throughout the entire depth of the tumor using fluorescent tomographic imaging; and 3) fluorescently labeled phage itself can serve as a replenishable molecular imaging agent. The described method should find widespread application in the rapid in vivo discovery and validation of affinity ligands and, importantly, in the use of fluorochrome-labeled phage clones as in vivo imaging agents.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17217618      PMCID: PMC1783712          DOI: 10.1593/neo.06610

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  43 in total

Review 1.  Evolving phage vectors for cell targeted gene delivery.

Authors:  David Larocca; Michael A Burg; Kristen Jensen-Pergakes; Edward Prenn Ravey; Ana Maria Gonzalez; Andrew Baird
Journal:  Curr Pharm Biotechnol       Date:  2002-03       Impact factor: 2.837

Review 2.  Shedding light onto live molecular targets.

Authors:  Ralph Weissleder; Vasilis Ntziachristos
Journal:  Nat Med       Date:  2003-01       Impact factor: 53.440

3.  Systems biology and new technologies enable predictive and preventative medicine.

Authors:  Leroy Hood; James R Heath; Michael E Phelps; Biaoyang Lin
Journal:  Science       Date:  2004-10-22       Impact factor: 47.728

4.  Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging.

Authors:  D A Sipkins; D A Cheresh; M R Kazemi; L M Nevin; M D Bednarski; K C Li
Journal:  Nat Med       Date:  1998-05       Impact factor: 53.440

5.  Detection of vascular adhesion molecule-1 expression using a novel multimodal nanoparticle.

Authors:  Kimberly A Kelly; Jennifer R Allport; Andrew Tsourkas; Vivek R Shinde-Patil; Lee Josephson; Ralph Weissleder
Journal:  Circ Res       Date:  2005-01-13       Impact factor: 17.367

6.  Nanoparticles for the optical imaging of tumor E-selectin.

Authors:  Martin Funovics; Xavier Montet; Fred Reynolds; Ralph Weissleder; Lee Josephson
Journal:  Neoplasia       Date:  2005-10       Impact factor: 5.715

7.  Enhanced growth of tumors in SPARC null mice is associated with changes in the ECM.

Authors:  Rolf A Brekken; Pauli Puolakkainen; David C Graves; Gail Workman; Sharon R Lubkin; E Helene Sage
Journal:  J Clin Invest       Date:  2003-02       Impact factor: 14.808

8.  Particularities of the vasculature can promote the organ specificity of autoimmune attack.

Authors:  Bryce A Binstadt; Pratik R Patel; Herlen Alencar; Peter A Nigrovic; David M Lee; Umar Mahmood; Ralph Weissleder; Diane Mathis; Christophe Benoist
Journal:  Nat Immunol       Date:  2006-01-29       Impact factor: 25.606

9.  Novel peptide ligands for integrin alpha 4 beta 1 overexpressed in cancer cells.

Authors:  Masahito Mikawa; Henry Wang; Linlang Guo; Ruiwu Liu; Jan Marik; Yoshikazu Takada; Kit Lam; Derick Lau
Journal:  Mol Cancer Ther       Date:  2004-10       Impact factor: 6.261

10.  Progressive vascular changes in a transgenic mouse model of squamous cell carcinoma.

Authors:  Jason A Hoffman; Enrico Giraudo; Mallika Singh; Lianglin Zhang; Masahiro Inoue; Kimmo Porkka; Douglas Hanahan; Erkki Ruoslahti
Journal:  Cancer Cell       Date:  2003-11       Impact factor: 31.743

View more
  44 in total

1.  Phage display peptide probes for imaging early response to bevacizumab treatment.

Authors:  Qizhen Cao; Shuanglong Liu; Gang Niu; Kai Chen; Yongjun Yan; Zhaofei Liu; Xiaoyuan Chen
Journal:  Amino Acids       Date:  2010-03-16       Impact factor: 3.520

2.  Imaging VCAM-1 as an indicator of treatment efficacy in metastatic ovarian cancer.

Authors:  Jennifer M Scalici; Stephanie Thomas; Christine Harrer; Timothy A Raines; Joanna Curran; Kristen A Atkins; Mark R Conaway; Linda Duska; Kimberly A Kelly; Jill K Slack-Davis
Journal:  J Nucl Med       Date:  2013-09-12       Impact factor: 10.057

3.  Development of Secreted Protein and Acidic and Rich in Cysteine (SPARC) Targeted Nanoparticles for the Prognostic Molecular Imaging of Metastatic Prostate Cancer.

Authors:  Stephanie Thomas; Peter Waterman; Suelin Chen; Brett Marinelli; Marc Seaman; Scott Rodig; Robert W Ross; Lee Josephson; Ralph Weissleder; Kimberly A Kelly
Journal:  J Nanomed Nanotechnol       Date:  2011-08

Review 4.  Multifunctional magnetic nanoparticles for targeted imaging and therapy.

Authors:  Jason R McCarthy; Ralph Weissleder
Journal:  Adv Drug Deliv Rev       Date:  2008-04-10       Impact factor: 15.470

5.  Detection of early prostate cancer using a hepsin-targeted imaging agent.

Authors:  Kimberly A Kelly; Sunita R Setlur; Robert Ross; Rajesh Anbazhagan; Peter Waterman; Mark A Rubin; Ralph Weissleder
Journal:  Cancer Res       Date:  2008-04-01       Impact factor: 12.701

6.  Landscape phage ligands for PC3 prostate carcinoma cells.

Authors:  P K Jayanna; D Bedi; P Deinnocentes; R C Bird; V A Petrenko
Journal:  Protein Eng Des Sel       Date:  2010-02-25       Impact factor: 1.650

Review 7.  Peptides and peptide hormones for molecular imaging and disease diagnosis.

Authors:  Seulki Lee; Jin Xie; Xiaoyuan Chen
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

8.  Near infrared fluorescence-based bacteriophage particles for ratiometric pH imaging.

Authors:  Scott A Hilderbrand; Kimberly A Kelly; Mark Niedre; Ralph Weissleder
Journal:  Bioconjug Chem       Date:  2008-07-31       Impact factor: 4.774

Review 9.  Imaging in the era of molecular oncology.

Authors:  Ralph Weissleder; Mikael J Pittet
Journal:  Nature       Date:  2008-04-03       Impact factor: 49.962

10.  Development of an optimized protocol for studying the interaction of filamentous bacteriophage with mammalian cells by fluorescence microscopy.

Authors:  Gopal Abbineni; Barbara Safiejko-Mroczka; Chuanbin Mao
Journal:  Microsc Res Tech       Date:  2010-05       Impact factor: 2.769

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.